Last reviewed · How we verify

NCT05786794: HHARC

Hearing Healthcare Assessment in Rural Communities

Recruiting now NA Last updated 5 September 2025
What this trial tests

NA trial testing Patient Navigation Program for Hearing Health Care in Hearing Loss, Adult-Onset in 500 participants. Currently enrolling.

Timeline
8 August 2024
Primary endpoint
31 July 2026
31 July 2026

Quick facts

Lead sponsorMatthew Bush, MD
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment500
Start date8 August 2024
Primary completion31 July 2026
Estimated completion31 July 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Matthew Bush, MD

Who can join

18 and older, any sex, with Hearing Loss, Adult-Onset or Hearing Loss, Age-Related. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adult hearing loss in is the third most common chronic health condition in the United States. Adults living in rural areas face a higher risk of experiencing hearing loss, and more difficulty receiving testing and treatment than adults in urban settings. The goal of this clinical trial is to develop and test a community-based hearing healthcare patient navigation program in rural Kentucky. The main question this study aims to answer is: -Can the number of rural adults receiving diagnostic hearing tests be increased?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hearing Loss, Adult-Onset

Currently open trials in the same condition.

Other Matthew Bush, MD trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05786794.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing